Eversept Partners’s Zogenix, Inc. ZGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-550,966
| Closed | -$8.95M | – | 119 |
|
|
2021
Q4 | $8.95M | Sell |
550,966
-223,625
| -29% | -$3.28M | 0.57% | 47 |
|
|
2021
Q3 | $11.8M | Buy |
774,591
+278,731
| +56% | +$4.35M | 0.81% | 35 |
|
|
2021
Q2 | $8.57M | Sell |
495,860
-327,369
| -40% | -$6.02M | 0.57% | 40 |
|
|
2021
Q1 | $16.1M | Sell |
823,229
-86,479
| -10% | -$1.77M | 1.21% | 28 |
|
|
2020
Q4 | $18.2M | Buy |
909,708
+44,467
| +5% | +$909K | 2.13% | 17 |
|
|
2020
Q3 | $15.5M | Sell |
865,241
-141,842
| -14% | -$3.48M | 3.45% | 12 |
|
|
2020
Q2 | $27.2M | Sell |
1,007,083
-1,006,384
| -50% | -$27.8M | 3.73% | 9 |
|
|
2020
Q1 | $49.8M | Buy |
2,013,467
+1,517,822
| +306% | +$55.3M | 12.38% | 1 |
|
|
2019
Q4 | $25.8M | Sell |
495,645
-148,173
| -23% | -$6.78M | 4.56% | 6 |
|
|
2019
Q3 | $25.8M | Buy |
643,818
+107,024
| +20% | +$4.93M | 8% | 4 |
|
|
2019
Q2 | $25.6M | Buy |
536,794
+41,365
| +8% | +$1.67M | 7.18% | 4 |
|
|
2019
Q1 | $27.3M | Sell |
495,429
-68,000
| -12% | -$3.24M | 7.95% | 4 |
|
|
2018
Q4 | $20.5M | Buy |
563,429
+144,150
| +34% | +$5.9M | 11.12% | 1 |
|
|
2018
Q3 | $20.8M | Buy |
419,279
+268,434
| +178% | +$13.7M | 9.13% | 2 |
|
|
2018
Q2 | $6.67M | Sell |
150,845
-53,701
| -26% | -$2.21M | 3.05% | 11 |
|
|
2018
Q1 | $8.19M | Sell |
204,546
-13,832
| -6% | -$549K | 3.8% | 12 |
|
|
2017
Q4 | $8.75M | Buy |
+218,378
| New | +$8.39M | 5.03% | 4 |
|
Eversept Partners's ZGNX Position: Q1 2022 in Review
Eversept Partners sold out of Zogenix, Inc. (ZGNX) in Q1 2022, closing a stake of 550,966 shares — an estimated $8.95M sold.
Eversept Partners first reported a position in ZGNX in Q4 2017 and held it in 17 quarters. The position peaked at $49.8M in Q1 2020. 0 funds tracked by Wall St. Rank hold ZGNX as of Q1 2022.
- Eversept Partners reported no remaining Zogenix, Inc. position as of Q1 2022 after selling out during the quarter.
- Eversept Partners sold 550,966 Zogenix, Inc. shares in Q1 2022, an estimated $8.95M.
- Eversept Partners first reported a position in Zogenix, Inc. in Q4 2017 and held it in 17 quarters.
- Eversept Partners's Zogenix, Inc. position peaked at $49.8M in Q1 2020.
- 0 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2022.
Based on Eversept Partners's 13F filing for Q1 2022, filed 16 May 2022.